J. Goldman & Co’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-360,000
| Closed | -$943K | – | 445 |
|
|
2020
Q4 | $943K | Buy |
+360,000
| New | +$943K | 0.05% | 195 |
|
|
2020
Q1 | – | Sell |
-73,510
| Closed | -$295K | – | 284 |
|
|
2019
Q4 | $295K | Sell |
73,510
-79,290
| -52% | -$318K | 0.02% | 153 |
|
|
2019
Q3 | $487K | Buy |
152,800
+52,799
| +53% | +$168K | 0.04% | 134 |
|
|
2019
Q2 | $390K | Buy |
+100,001
| New | +$390K | 0.03% | 143 |
|
|
2018
Q3 | – | Sell |
-40,684
| Closed | -$879K | – | 288 |
|
|
2018
Q2 | $879K | Sell |
40,684
-49,518
| -55% | -$1.07M | 0.05% | 163 |
|
|
2018
Q1 | $1.74M | Sell |
90,202
-17,798
| -16% | -$343K | 0.07% | 142 |
|
|
2017
Q4 | $1.5M | Buy |
+108,000
| New | +$1.5M | 0.08% | 124 |
|